Comparison of Standard of Care with or Without a PD-1/Pdl-1 Inhibitor for the Treatment of Multiple Myeloma: A Meta-Analysis of Phase II and III Randomized Controlled Trials
BLOOD（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined